Skip to main content
Caplight Logo









HealthMate

HealthMate

Private
SpainHealthcare & Life Scienceshttps://www.healthmate.tech/

Last Round

Accelerator

Mar 5, 2026

Total Funding Raised

$575,000

Momentum

Top 5%

of companies Caplight tracks

Company Overview

HealthMate is a health-tech company that provides an AI-powered clinic management platform for private clinics, featuring patient CRM, automated scheduling, billing, and AI-driven communication tools.

Sector

Healthcare & Life Sciences

Verticals

EHR & EMR, NLP & Conversational AI, Patient Engagement, Vertical SaaS, CRM

Business Model

B2B

Customer Profile

Subscription SaaS

AI Layer

Application

Keywords

clinic management softwareelectronic health recordsEHRAI voice agentpatient engagementmedical practice managementAI receptionistWhatsApp automationvertical SaaSpatient CRMappointment scheduling softwareconversational AImedical billing softwarehealthcare automationAI scribe

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

HealthMate Comparables

Compare HealthMate with similar companies based on industry and business-model similarity.

HealthMate comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Nubimed
88%
Ovianta Technologies
85%
Halthia
82%

HealthMate Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorMar 5, 2026
Pre SeedJul 1, 2025

Key People

Founding team and executive leadership

Marcos Valera Santana

CEO and co-founder, CEO and Co-Founder

Founding Team

Roberto Oliver González

CTO

Executive Team

Adrian Montero Martinez

Fractional CFO

Executive Team

HealthMate Investors

Notable investors and investment history

HealthMate investors
InvestorRounds
LanzaderaAccelerator
Empresa Nacional de InnovaciónPre Seed
BcombinatorPre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 15, 2026

    Grew 40% QoQ from 10 to 14 employees.

  • Sep 12, 2026

    Monthly visitors increased 311% MoM, reaching 6.7K.

HealthMate Filings

Explore SEC and related filing metadata, where available.

HealthMate filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about HealthMate's valuation, stock price, and market status.

Is HealthMate a public or private company?

HealthMate is a private company.

What is the current stock price of HealthMate?

HealthMate is a private company, so its shares have no public market price. Caplight tracks HealthMate's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is HealthMate worth (valuation)?

Valuation information for HealthMate is not publicly available.

Can I buy HealthMate stock?

HealthMate shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was HealthMate's last funding round?

HealthMate's most recent funding round was Accelerator on March 5, 2026.

Who are the main investors in HealthMate?

Key investors in HealthMate include Bcombinator.

Will HealthMate IPO soon?

No public IPO plans have been announced for HealthMate.

How can I track HealthMate secondary market activity?

Caplight tracks bids, offers, and trades in HealthMate's shares on secondary markets.

Firmographic Details

HeadquartersSpain
Employee Range13
Year FoundedN/A
Last FundingMar 5, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?